Related Experiment Videos
An interference-free implantable glucose microbiosensor based on use of a polymeric analyte regulating membrane
Hong Xie1, Xiu Ling Tan, Zhiqiang Gao
1Institute of Bioengineering and Nanotechnology, Biopolis Way, Singapore 138669.
Frontiers in Bioscience : a Journal and Virtual Library
|March 17, 2005
Summary
A new implantable glucose biosensor uses a special coating for accurate blood sugar monitoring. Clinical trials show this device correlates well with blood glucose levels, offering a promising tool for diabetes management.
Area of Science:
- Biomedical Engineering
- Electrochemistry
- Biosensors
Background:
- Accurate glucose monitoring is crucial for diabetes management.
- Existing glucose biosensors face challenges with selectivity and stability.
- Development of implantable biosensors requires robust analyte-regulating membranes.
Purpose of the Study:
- To develop an implantable glucose microbiosensor with enhanced selectivity and sensitivity.
- To evaluate the performance of a hydrophilic poly(4-vinyl pyridine-co-acrylic acid) (PVP-PAC) overcoating as an analyte-regulating membrane.
- To assess the clinical correlation of the developed biosensor with blood glucose levels.
Main Methods:
- Fabrication of a gold microelectrode with an electrodeposited redox polymer/glucose oxidase (GOX) sensing membrane.
- Application of a poly(4-vinyl pyridine-co-acrylic acid) (PVP-PAC) overcoating, cross-linked with poly(ethylene glycol) diglycidyl ether (PEGDGE).
- Amperometric measurements to determine sensitivity, selectivity, dynamic range, and response time.
Main Results:
- The PVP-PAC overcoated biosensor exhibited high current sensitivity (approx. 220 nA/mM glucose) compared to PVP (approx. 30 nA/mM).
- The biosensor demonstrated excellent selectivity for glucose against oxygen and ascorbic acid.
- A dynamic glucose detection range of 0–30 mM with a response time <10 sec was achieved.
- Clinical trials indicated good correlation between implanted biosensor readings and blood sugar levels.
Conclusions:
- The developed implantable glucose microbiosensor with a PVP-PAC overcoating shows high sensitivity and selectivity.
- The biosensor is a promising device for continuous and accurate glucose monitoring in clinical settings.
- Further validation in extensive clinical trials could establish its utility for diabetes management.